Yesterday's New York Times carried - for the second time in a week - a story highlighting the legal strategy the Johnson & Johnson affiliate company, Cordis Corp., took in a patent dispute with Boston Scientific. Last week, Cordis’s communications staff provided the newspaper with a statement explaining that case, but they chose not to include or reference the points raised in that statement in yesterday's article. Have a look at their statement.
Health & Wellness
For Your Consideration